[HTML][HTML] Diabetic neuropathy: a position statement by the American Diabetes Association

R Pop-Busui, AJM Boulton, EL Feldman, V Bril… - Diabetes …, 2017 - ncbi.nlm.nih.gov
Diabetic neuropathies are the most prevalent chronic complications of diabetes. This
heterogeneous group of conditions affects different parts of the nervous system and presents …

What we know about primary dysmenorrhea today: a critical review

S Iacovides, I Avidon, FC Baker - Human reproduction update, 2015 - academic.oup.com
BACKGROUND Primary dysmenorrhea, or painful menstruation in the absence of pelvic
pathology, is a common, and often debilitating, gynecological condition that affects between …

[HTML][HTML] CDC clinical practice guideline for prescribing opioids for pain—United States, 2022

D Dowell - MMWR. Recommendations and reports, 2022 - cdc.gov
This guideline provides recommendations for clinicians providing pain care, including those
prescribing opioids, for outpatients aged≥ 18 years. It updates the CDC Guideline for …

American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update

L Blonde, GE Umpierrez, SS Reddy, JB McGill… - Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

A nerve injury–specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression

S Du, S Wu, X Feng, B Wang, S Xia… - The Journal of …, 2022 - Am Soc Clin Investig
Maladaptive changes of nerve injury–associated genes in dorsal root ganglia (DRGs) are
critical for neuropathic pain genesis. Emerging evidence supports the role of long noncoding …

Interdisciplinary chronic pain management: past, present, and future.

RJ Gatchel, DD McGeary, CA McGeary… - American …, 2014 - psycnet.apa.org
Chronic pain is a significant and costly problem in the United States as well as throughout
the industrialized world. Unfortunately, there have been concerns about the effectiveness of …

Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy

KM Winters-Stone, F Horak, PG Jacobs… - Journal of clinical …, 2017 - ascopubs.org
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment
ends and may lead to functional decline and falls. This study compared objective and self …

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

N Attal, G Cruccu, R Baron, M Haanpää… - European journal of …, 2010 - Wiley Online Library
Background and objectives: This second European Federation of Neurological Societies
Task Force aimed at updating the existing evidence about the pharmacological treatment of …

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

RH Dworkin, AB O'Connor, J Audette, R Baron… - Mayo Clinic …, 2010 - Elsevier
The Neuropathic Pain Special Interest Group of the International Association for the Study of
Pain recently sponsored the development of evidence-based guidelines for the …

TNF-α and neuropathic pain-a review

L Leung, CM Cahill - Journal of neuroinflammation, 2010 - Springer
Tumor necrosis factor alpha (TNF-α) was discovered more than a century ago, and its known
roles have extended from within the immune system to include a neuro-inflammatory domain …